- Home
- BGLC vs NCPL Comparison
BGLC vs NCPL Comparison
Compare BGLC & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGLC
- NCPL
- Stock Information
- Founded
- BGLC 2017
- NCPL 1984
- Country
- BGLC Malaysia
- NCPL United States
- Employees
- BGLC N/A
- NCPL N/A
- Industry
- BGLC Medical Specialities
- NCPL Investment Managers
- Sector
- BGLC Health Care
- NCPL Finance
- Exchange
- BGLC Nasdaq
- NCPL Nasdaq
- Market Cap
- BGLC 5.0M
- NCPL 4.3M
- IPO Year
- BGLC N/A
- NCPL N/A
- Fundamental
- Price
- BGLC $2.71
- NCPL $5.34
- Analyst Decision
- BGLC
- NCPL
- Analyst Count
- BGLC 0
- NCPL 0
- Target Price
- BGLC N/A
- NCPL N/A
- AVG Volume (30 Days)
- BGLC 69.9K
- NCPL 638.1K
- Earning Date
- BGLC 08-13-2025
- NCPL 07-28-2025
- Dividend Yield
- BGLC N/A
- NCPL N/A
- EPS Growth
- BGLC N/A
- NCPL N/A
- EPS
- BGLC N/A
- NCPL N/A
- Revenue
- BGLC $9,265,870.00
- NCPL $812,612.00
- Revenue This Year
- BGLC N/A
- NCPL N/A
- Revenue Next Year
- BGLC N/A
- NCPL $101.16
- P/E Ratio
- BGLC N/A
- NCPL N/A
- Revenue Growth
- BGLC N/A
- NCPL N/A
- 52 Week Low
- BGLC $2.01
- NCPL $1.41
- 52 Week High
- BGLC $8.40
- NCPL $11.90
- Technical
- Relative Strength Index (RSI)
- BGLC 43.64
- NCPL 71.16
- Support Level
- BGLC $2.60
- NCPL $3.90
- Resistance Level
- BGLC $3.06
- NCPL $5.06
- Average True Range (ATR)
- BGLC 0.21
- NCPL 0.72
- MACD
- BGLC -0.06
- NCPL 0.18
- Stochastic Oscillator
- BGLC 16.27
- NCPL 69.64
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.